HitGen-DNA Encoded Library-Drug Discovery
中文 English
中文 English
  688222
RMB
  • Highest
  • Lowest
  • Volume
  • Amount
Up to     Beijing time. There is 15-minute delay in the quoted price.

Investors

Basic Information
HitGen is a biotech company focused on lead generation and optimization of innovative drug discovery research process. HitGen has its headquarters based in Chengdu, China. Its core technology is centered around the synthesis and screening of a rapidly expanding and proprietary DNA-encoded compound libraries of novel small and macrocyclic molecules for lead generation.
HitGen Inc.
Stock Code 688222 Registered Capital 400,680,000.00
Registered Address Registered Address Building 1 Floor 3, No.88 South Keyuan Road, Hi-Tech Zone, Chengdu, Sichuan
Main Business DNA encoded libraries screening, customized design and synthesis of DNA encoded library, specialized chemistry & bioscience services, and innovative drug discovery project licensing.

The Board Office is in charge of the information disclosure and investor relations. The secretary of the board is Shiwei Geng.

Tel: +86 28 85197385 E-mail: investors@hitgen.com
info@hitgen.com

返回顶部
Contact Us
  • Building 6, No.8, Huigu 1st East Road Tianfu International Bio-Town Shuangliu District, Chengdu City, Sichuan Province, P. R. China
  • Tel：+86 28 85197385
WeChat Account

  • 成都先导

  • 先导药物

Linkedin

返回顶部